Red flags / Material weakness

HSCSHeartSciences Inc.ElevatedForm 10-Qfiled Sep 14, 4:14 PM ET

HeartSciences says disclosure controls were not effective at July 31, 2026 due to material weaknesses

HeartSciences reports that its CEO and CFO concluded disclosure controls and procedures were not effective as of July 31, 2026, because of three identified material weaknesses in internal control over financial reporting, including insufficient U.S. GAAP and SEC accounting resources and too few staff for segregation of duties. The company says these weaknesses are not yet remediated and that remediation will not be considered complete until controls are tested and shown to operate effectively. Unremediated control weaknesses of this kind can raise the risk of misstated financial statements and may affect the company's ability to meet reporting obligations.

“Based upon the most recent evaluation of internal controls over financial reporting, our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer) determined that our disclosure controls and procedures were not effective as of July 31, 2026 as a result of identified material weaknesses in our internal control over financial reporting.”

What the stock did

From the last close before the filing was public. Market cap now: $10M.

1 day
-2.8%
SPY -0.5%
5 days
+32.2%
SPY +1.7%
20 days
-6.8%
SPY +2.3%

10-K or 10-Q reports a material weakness in internal control that is not fixed. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on HSCS

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 19, 9:18 AM ETHSCS
HeartSciences Inc.
Dilution
ElevatedForm 424B5
HeartSciences files to sell up to $3.08 million of common stock through Maxim ATM program$10M--
Sep 25, 5:00 PM ETHSCS
HeartSciences Inc.
Dilution
WatchForm S-3
HeartSciences Inc. filed a new S-3 shelf registration$10M-9.1%-33.6%
Sep 14, 4:14 PM ETHSCS
HeartSciences Inc.
Going concern
ElevatedForm 10-Q
HeartSciences flags substantial doubt about going concern as losses and stockholders' deficit mount$10M+32.2%-6.8%